← Open Payments lookup

VIVIAN KAMAU: Open Payments

NPI 1700472362 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$469 in 20 payments from 5 companies in 2025. Trend: 2023 $128 · 2024 $253 · 2025 $469

Food & beverage: $469
CompanyPaymentsAmount
Axsome Therapeutics, Inc.7$199
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$95
Otsuka America Pharmaceutical, Inc.3$71
Alkermes, Inc.3$57
Vanda Pharmaceuticals Inc.2$47

Products named: Auvelity, CAPLYTA, REXULTI, ARISTADA, HETLIOZ.

Industry payments across MD — which companies pay providers there.